[go: up one dir, main page]

DK1601680T3 - Fremgangsmåder til fremstilling af organiske jern(iii)forbindelser - Google Patents

Fremgangsmåder til fremstilling af organiske jern(iii)forbindelser

Info

Publication number
DK1601680T3
DK1601680T3 DK04712312.0T DK04712312T DK1601680T3 DK 1601680 T3 DK1601680 T3 DK 1601680T3 DK 04712312 T DK04712312 T DK 04712312T DK 1601680 T3 DK1601680 T3 DK 1601680T3
Authority
DK
Denmark
Prior art keywords
procedures
iii
manufacturing organic
organic iron
iron
Prior art date
Application number
DK04712312.0T
Other languages
English (en)
Inventor
David W K Kwok
Nikolay Mintchev Stoynov
Original Assignee
Panion & Bf Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32912273&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1601680(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Panion & Bf Biotech Inc filed Critical Panion & Bf Biotech Inc
Application granted granted Critical
Publication of DK1601680T3 publication Critical patent/DK1601680T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02—Iron compounds
    • C07F15/025—Iron compounds without a metal-carbon linkage
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/04—Chelating agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/41—Preparation of salts of carboxylic acids
    • C07C51/412—Preparation of salts of carboxylic acids by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/41—Preparation of salts of carboxylic acids
    • C07C51/418—Preparation of metal complexes containing carboxylic acid moieties
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/265—Citric acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02—Iron compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/41—Preparation of salts of carboxylic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Plant Pathology (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Hematology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK04712312.0T 2003-02-19 2004-02-18 Fremgangsmåder til fremstilling af organiske jern(iii)forbindelser DK1601680T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US44769003P 2003-02-19 2003-02-19
US46268403P 2003-04-15 2003-04-15
PCT/US2004/004646 WO2004074444A2 (en) 2003-02-19 2004-02-18 Ferric organic compounds, uses thereof and methods of making same

Publications (1)

Publication Number Publication Date
DK1601680T3 true DK1601680T3 (da) 2014-10-06

Family

ID=32912273

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04712312.0T DK1601680T3 (da) 2003-02-19 2004-02-18 Fremgangsmåder til fremstilling af organiske jern(iii)forbindelser

Country Status (18)

Country Link
US (12) US7767851B2 (da)
EP (3) EP2813511A3 (da)
JP (1) JP4964585B2 (da)
KR (1) KR101149706B1 (da)
CN (1) CN100386336C (da)
AU (1) AU2004213819B2 (da)
CA (1) CA2516471C (da)
CY (1) CY1115602T1 (da)
DK (1) DK1601680T3 (da)
EA (1) EA010028B1 (da)
ES (1) ES2503717T3 (da)
HK (1) HK1205129A1 (da)
MX (1) MXPA05008784A (da)
NZ (1) NZ541991A (da)
PT (1) PT1601680E (da)
SI (1) SI1601680T1 (da)
TW (1) TWI335218B (da)
WO (1) WO2004074444A2 (da)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8093423B2 (en) 2003-02-19 2012-01-10 Globoasia, Llc Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same
US20220144872A1 (en) * 2003-02-19 2022-05-12 Panion & Bf Biotech Inc. Pharmaceutical-Grade Ferric Organic Compounds, Uses Thereof and Methods of Making Same
TWI335218B (en) 2003-02-19 2011-01-01 Panion & Bf Biotech Inc Ferric organic compounds, uses thereof and methods of making same
ES2539635T3 (es) * 2005-08-18 2015-07-02 Panion & Bf Biotech Inc. Citrato férrico de grado farmacéutico para uso médico
CN100591654C (zh) * 2005-11-30 2010-02-24 苏荣仁 一种可提高枸橼酸铁溶解度的精制方法
ES2699447T3 (es) * 2006-01-30 2019-02-11 Panion & Bf Biotech Inc Citrato férrico para revertir, prevenir, retrasar o estabilizar la calcificación de tejidos blandos
US8932648B2 (en) * 2006-01-30 2015-01-13 Globoasia, Llc Method of selecting phosphate binder and its uses thereof
JP5756598B2 (ja) 2007-02-06 2015-07-29 メディカル リサーチ カウンシル リガンド修飾ポリオキソヒドロキシ金属イオン物質、それらの使用およびそれらの調製方法
US7816404B2 (en) * 2007-07-20 2010-10-19 Rockwell Medical Technologies, Inc. Methods for the preparation and use of ferric pyrophosphate citrate chelate compositions
KR100905403B1 (ko) * 2007-10-18 2009-06-30 한국지질자원연구원 저품위 철광석을 이용한 아세트산 철(ⅱ)의 제조방법
GB0814326D0 (en) * 2008-08-05 2008-09-10 Medical Res Council Phosphate binding materials and their uses
AU2014218455B2 (en) * 2009-07-21 2016-11-24 Keryx Biopharmaceuticals, Inc. Ferric Citrate Dosage Forms
MX2012000892A (es) 2009-07-21 2012-06-01 Keryx Biopharmaceuticals Inc Formas de dosificacion de citrato ferrico.
US9174846B2 (en) * 2009-09-18 2015-11-03 A123 Systems Llc Ferric phosphate and methods of preparation thereof
US9660267B2 (en) 2009-09-18 2017-05-23 A123 Systems, LLC High power electrode materials
EP2594277A4 (en) * 2010-07-07 2014-01-01 Japan Tobacco Inc TABLET WITH IRON CITRATE
US9199863B2 (en) 2011-01-03 2015-12-01 The Board Of Regents For Oklahoma State University Iron coordination polymers for adsorption of arsenate and phosphate
SG11201404168SA (en) * 2011-01-18 2014-10-30 Japan Tobacco Inc FERRIC CITRATE CONTAINING SUBSTANTIALLY NO β-OXIDIZED IRON HYDROXIDE
GB201113538D0 (en) 2011-08-04 2011-09-21 Karobio Ab Novel estrogen receptor ligands
DE102011112898A1 (de) 2011-09-08 2013-03-14 Charité - Universitätsmedizin Berlin Nanopartikuläres Phosphatadsorbens basierend auf Maghämit oder Maghämit/Magnetit, dessen Herstellung und Verwendungen
US9731999B2 (en) 2011-09-23 2017-08-15 Iqbal Gill Chemical admixtures for hydraulic cements
ES2796254T3 (es) * 2012-06-21 2020-11-26 Keryx Biopharmaceuticals Inc Uso de citrato férrico en el tratamiento de pacientes con enfermedad renal crónica
DK3003327T3 (da) 2013-06-05 2017-10-23 Tricida Inc Proton-bindende polymerer til oral indgivelse
EP3065734A4 (en) 2013-11-04 2017-05-17 Keryx Biopharmaceuticals, Inc. Ferric citrate for reducing cardiac failure in chronic kidney disease patients
WO2015110968A1 (en) * 2014-01-23 2015-07-30 Lupin Limited Pharmaceutical grade ferric citrate and method for its production
EP3157516A4 (en) 2014-06-22 2017-12-13 Dexcel Pharma Technologies Ltd. Pharmaceutical compositions comprising ferric citrate and methods for the production thereof
MA48486B1 (fr) 2014-12-10 2021-03-31 Tricida Inc Polymères liant les protons pour administration orale
WO2016098131A2 (en) * 2014-12-17 2016-06-23 Biophore India Pharmaceuticals Pvt. Ltd. Improved method for the synthesis of ferric oraganic compounds
JP6206420B2 (ja) * 2015-01-13 2017-10-04 テクノサイエンス株式会社 クエン酸第二鉄を高濃度で含有するゲル状組成物の製造方法
TWI812580B (zh) * 2015-03-04 2023-08-21 美商凱克斯生物製藥公司 檸檬酸鐵用於治療缺鐵性貧血之用途
WO2016162794A1 (en) * 2015-04-08 2016-10-13 Leiutis Pharmaceuticals Pvt Ltd Pharmaceutical compositions of ferric citrate
WO2016162888A1 (en) 2015-04-09 2016-10-13 Actavis Group Ptc Ehf. Process for preparing pharmaceutical grade ferric citrate
JP2018526349A (ja) 2015-08-05 2018-09-13 ルピン・リミテッド 医薬品グレードのクエン酸第二鉄の調製のためのプロセス
GB201517893D0 (en) 2015-10-09 2015-11-25 Medical Res Council Methods for producing carboxylate ligand modified ferric iron hydroxide colloids
JP7033545B2 (ja) * 2016-03-31 2022-03-10 シールド ティーエックス （ユーケー） リミテッド 配位子修飾及び配位子コーティングされた水酸化第二鉄からマルトール第二鉄組成物を生成するための方法
MX2018013476A (es) 2016-05-06 2019-03-28 Tricida Inc Composiciones para tratar trastornos acido-base.
WO2019012552A1 (en) * 2017-07-12 2019-01-17 Ra Chem Pharma COMPOSITIONS OF FERRIC ORGANIC COMPOUNDS
WO2019012553A1 (en) * 2017-07-12 2019-01-17 Ra Chem Pharma PROCESS FOR THE PREPARATION OF COMPOSITIONS OF FERRIC ORGANIC COMPOUNDS
US10934380B1 (en) 2017-09-25 2021-03-02 Tricida, Inc. Crosslinked poly(allylamine) polymer pharmaceutical compositions
IL319146A (en) 2017-11-03 2025-04-01 Tricida Inc Compositions for and method of treating acid-base disorders
US11466042B2 (en) 2017-11-10 2022-10-11 Tokuyama Corporation Method for producing ferric citrate hydrate
CN111032612A (zh) * 2018-01-22 2020-04-17 株式会社德山 柠檬酸铁的制造方法
WO2020100911A1 (ja) * 2018-11-14 2020-05-22 株式会社トクヤマ クエン酸第二鉄水和物の製造方法
WO2020100912A1 (ja) * 2018-11-14 2020-05-22 株式会社トクヤマ クエン酸第二鉄水和物の製造方法
JP7175235B2 (ja) * 2019-04-19 2022-11-18 株式会社トクヤマ クエン酸第二鉄水和物の製造方法
WO2020243674A1 (en) 2019-05-30 2020-12-03 Compass Minerals Usa Inc. Micronutrient foliar solutions
WO2021089766A1 (en) 2019-11-08 2021-05-14 Química Sintética, S.A. Process for the preparation of ferric organic compounds
GB202005054D0 (en) 2020-04-06 2020-05-20 Nemysis Ltd Carboxylate Ligand Modified Ferric Iron Hydroxide Compositions for Use in the Treatment or Prevention of Iron Deficiency Associated with Liver Diseases
US20210332073A1 (en) * 2020-04-26 2021-10-28 RK Pharma Solutions LLC Process for the preparation of ferric citrate
WO2022251563A1 (en) 2021-05-27 2022-12-01 Keryx Biopharmaceuticals, Inc. Pediatric formulations of ferric citrate
WO2025096992A1 (en) * 2023-11-01 2025-05-08 Navinta, Llc Process for isolation of solid ferric derisomaltose

Family Cites Families (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2644828A (en) * 1949-06-10 1953-07-07 Mallinckrodt Chemical Works Crystalline ferric ammonium citrate compounds
DE1131360B (de) 1957-11-26 1962-06-14 Vitarine Company Inc Verfahren zum Stabilisieren von waessrigen Loesungen, die neben Vitamin B noch Vitamin B und Vitamin C enthalten
SU142643A1 (ru) 1961-03-25 1961-11-30 В.Б. Тихомиров Способ извлечени соединений железа из водной фазы
AT279048B (de) * 1967-07-04 1970-02-25 Pharmazeutische Fabrik Montavit Gmbh Verfahren zur Herstellung neuer, löslicher und stabiler organischer Eisen(III)-Komplexverbindungen und Injektionslösungen davon
GB1224589A (en) * 1969-10-06 1971-03-10 Gerhard Gergely Complex iron salts
PL69800B1 (da) * 1970-06-01 1973-10-31
US4180567A (en) * 1977-09-02 1979-12-25 Pharmachem Corporation Iron preparations and methods of making and administering the same
JPS5626709A (en) * 1979-08-04 1981-03-14 Nichia Kagaku Kogyo Kk Manufacture of water soluble iron salt
DE3228231A1 (de) 1982-07-28 1984-02-02 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., 8000 München Arzneimittel, calciummischsalze von polymeren, anionischen carbonsaeuren und/oder schwefelsaeureestern, verfahren zu ihrer herstellung und ihre verwendung
IT1222654B (it) * 1987-09-14 1990-09-12 Schering Ag Complesso micellare di ferro-citrato
GB2212396A (en) 1987-12-18 1989-07-26 Procter & Gamble Dietary supplement comprising calcium and delayed release coated iron
US5602116A (en) 1988-08-02 1997-02-11 Bone Care International, Inc. Method for treating and preventing secondary hyperparathyroidism
US4970079A (en) 1989-06-05 1990-11-13 Purdue Research Foundation Method and composition of oxy-iron compounds for treatment of hyperphosphatemia
JP2523057B2 (ja) 1990-10-31 1996-08-07 有限会社丸吉商事 多重ポリ袋の製造方法及び製造装置
CA2057184C (en) * 1990-12-13 1996-11-19 Hisaki Abe Active carbon materials, process for the preparation thereof and the use thereof
JPH05155776A (ja) * 1991-12-02 1993-06-22 Otsuka Pharmaceut Factory Inc 高リン血症治療剤
DE4239442C2 (de) 1992-11-24 2001-09-13 Sebo Gmbh Verwendung eines mit polynuklearen Metalloxidhydroxiden modifizierten Adsorptionsmaterials zur selektiven Elimination von anorganischem Phosphat aus proteinhaltigen Flüssigkeiten
DE59506534D1 (de) * 1994-05-25 1999-09-09 Siemens Ag Trockenentwickelbarer positivresist
JP3302178B2 (ja) 1994-06-22 2002-07-15 日本クラウンコルク株式会社 合成樹脂製容器蓋
CA2160423A1 (en) * 1994-11-02 1996-05-03 Hemant N. Joshi Salts of nefazodone having improved dissolution rates
JPH08198760A (ja) 1995-01-20 1996-08-06 Japan Organo Co Ltd 経口用リン酸イオン吸着剤
DE19638044A1 (de) 1996-09-18 1998-03-19 Bayer Ag Immunogene Peptide von Maul- und Klauenseuchen-Viren
JP4024891B2 (ja) * 1996-12-10 2007-12-19 株式会社キレスト技研 アミノポリカルボン酸第二鉄塩の製法
US5753706A (en) 1996-12-16 1998-05-19 Hsu; Chen Hsing Methods for treating renal failure
RU2188033C2 (ru) 1997-03-18 2002-08-27 Рош Диагностикс Гмбх Комбинированные фармацевтические препараты, содержащие эритропоэтин и препараты железа
TW374018B (en) 1997-03-31 1999-11-11 Chen Hsing Hsu Composition for treating renal failure
US6143243A (en) 1997-12-29 2000-11-07 Prestone Products Corporation Method of inhibiting cavitation-erosion corrosion of aluminum surfaces using carboxylic acid based compositions comprising polymerizable-acid graft polymers
CA2240214A1 (en) 1998-05-05 1999-11-05 James Thomas Beck Process for the production of hydrogen by solar decomposition of water
CN1315174A (zh) 2000-03-31 2001-10-03 苏荣仁 治疗肾衰的药物组合物
US6649898B1 (en) * 2000-06-30 2003-11-18 Intel Corporation Method and apparatus for optically enabling a circuit component in a large scale integrated circuit
EP1392112A4 (en) 2001-05-07 2007-08-22 Cedars Sinai Medical Center ANIMAL KNOCKOUT SCA2 AND METHODS OF USE
US6887897B2 (en) 2001-07-31 2005-05-03 Mission Pharmacal Company Calcium glutarate supplement and phosphorus binder
CN1202067C (zh) 2002-09-09 2005-05-18 苏荣仁 药用级枸橼酸铁的制备方法
KR100519387B1 (ko) 2002-10-28 2005-10-10 이승재 뇌파에 따라 경사 조절이 가능한 침대장치 및 조절방법
US8093423B2 (en) 2003-02-19 2012-01-10 Globoasia, Llc Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same
TWI335218B (en) 2003-02-19 2011-01-01 Panion & Bf Biotech Inc Ferric organic compounds, uses thereof and methods of making same
TWI605718B (zh) 2003-06-17 2017-11-11 半導體能源研究所股份有限公司 具有攝像功能之顯示裝置及雙向通訊系統
KR100511227B1 (ko) 2003-06-27 2005-08-31 박상래 휴대용 감시 카메라 및 이를 이용한 개인 방범 시스템
TWI259772B (en) 2003-09-04 2006-08-11 Panion & Bf Biotech Inc Medical composition comprising ferric citrate, ferric citrate in medical grade and preparation thereof, and dietary nutriment comprising ferric citrate
CN1600302A (zh) 2003-09-22 2005-03-30 宝龄富锦生技股份有限公司 含有柠檬酸铁的医药组合物以及药用级柠檬酸铁及其制法和含有药用级柠檬酸铁的膳食营养品
US6903235B2 (en) 2003-10-08 2005-06-07 Panion & Bf Biotech Inc. Pharmaceutical-grade ferric citrate
KR20060003971A (ko) 2004-07-05 2006-01-12 김용화 마이샵
TW200637869A (en) * 2005-01-28 2006-11-01 Chugai Pharmaceutical Co Ltd The spiroketal derivatives and the use as therapeutical agent for diabetes of the same
ES2539635T3 (es) 2005-08-18 2015-07-02 Panion & Bf Biotech Inc. Citrato férrico de grado farmacéutico para uso médico
KR100662752B1 (ko) 2005-10-04 2007-01-02 엘에스산전 주식회사 다극 배선용 차단기
JP4692234B2 (ja) 2005-11-10 2011-06-01 ソニー株式会社 変調テーブル、変調装置および方法、プログラム、並びに記録媒体
ES2699447T3 (es) 2006-01-30 2019-02-11 Panion & Bf Biotech Inc Citrato férrico para revertir, prevenir, retrasar o estabilizar la calcificación de tejidos blandos
KR20080094013A (ko) 2006-01-30 2008-10-22 글로보아시아 엘엘씨 연조직의 석회화 역전, 예방, 지연 또는 안정화 방법
AU2007224576A1 (en) 2006-03-14 2007-09-20 Basf Se Method of inducing tolerance of plants against bacterioses
KR20080000070A (ko) 2006-06-26 2008-01-02 현대자동차주식회사 스마트 키를 이용한 트렁크의 개폐 제어방법 및 이에적용되는 스마트 키와 글로브 박스 잠금장치
CN101019848B (zh) 2006-11-17 2010-09-15 苏荣仁 枸橼酸铁在制备防治血管钙化的药物中的应用
US8795877B2 (en) 2007-05-31 2014-08-05 Lg Chem, Ltd. Electrical connecting member of assembling type and secondary battery pack containing the same
JP5526466B2 (ja) 2007-07-17 2014-06-18 株式会社大林組 耐火セグメントの製造方法
CN101235186B (zh) 2008-01-03 2010-08-11 中国船舶重工集团公司第七二五研究所 一种无溶剂可自分层固化的环氧-有机硅组合物
US8167237B2 (en) * 2008-03-21 2012-05-01 United Technologies Corporation Mounting system for a gas turbine engine
JP5787754B2 (ja) 2008-06-27 2015-09-30 コモンウェルス サイエンティフィック アンド インダストリアル リサーチ オーガナイゼーション 溶融材料を噴霧するロータリーアトマイザー
US8984607B1 (en) * 2012-04-20 2015-03-17 Wells Fargo Bank, N.A. Authentication system and method
TWI646091B (zh) * 2012-12-28 2019-01-01 日商衛斯克慧特股份有限公司 鹽類及晶形
SI3143027T1 (sl) * 2014-05-12 2019-10-30 Alfasigma Spa Nova solvatirana kristalna oblika rifaksimina, proizvodnja, sestavki in uporaba le-teh
EP3237405A1 (en) * 2014-12-26 2017-11-01 Cipla Limited Polymorphic forms of methyl((1s)-1-(((2s)-2-(5-(4'-(2-((2s)-1-((2s)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)-2-pyrrolidinyl)-1h-imidazol-5-yl)-4-biphenylyl)-1h-imidazol-2-yl)-1-pyrrolidinyl) carbonyl)-2-methylpropyl)carbamate and salts thereof

Also Published As

Publication number Publication date
HK1077580A1 (en) 2006-02-17
TWI335218B (en) 2011-01-01
WO2004074444A2 (en) 2004-09-02
US20170095441A1 (en) 2017-04-06
EP1601680B8 (en) 2014-11-26
NZ541991A (en) 2008-10-31
US8609896B2 (en) 2013-12-17
CN1751056A (zh) 2006-03-22
US20190055274A1 (en) 2019-02-21
EP2360139A2 (en) 2011-08-24
AU2004213819B2 (en) 2009-08-27
US8754258B2 (en) 2014-06-17
US20140011872A1 (en) 2014-01-09
EA200501322A1 (ru) 2006-04-28
EP2813511A3 (en) 2014-12-31
CA2516471C (en) 2013-04-09
US20100217025A1 (en) 2010-08-26
EP1601680B1 (en) 2014-06-25
US20150232495A1 (en) 2015-08-20
SI1601680T1 (sl) 2014-11-28
AU2004213819A1 (en) 2004-09-02
US9328133B2 (en) 2016-05-03
US20220213133A1 (en) 2022-07-07
EP1601680A2 (en) 2005-12-07
US7767851B2 (en) 2010-08-03
US20130079537A1 (en) 2013-03-28
WO2004074444A3 (en) 2005-04-14
ES2503717T3 (es) 2014-10-07
EP2360139A3 (en) 2012-04-11
US20190269722A1 (en) 2019-09-05
KR20050107428A (ko) 2005-11-11
US8901349B2 (en) 2014-12-02
KR101149706B1 (ko) 2012-05-23
EA010028B1 (ru) 2008-06-30
JP4964585B2 (ja) 2012-07-04
JP2006518391A (ja) 2006-08-10
TW200416027A (en) 2004-09-01
CA2516471A1 (en) 2004-09-02
PT1601680E (pt) 2014-09-23
HK1205129A1 (en) 2015-12-11
US8338642B2 (en) 2012-12-25
US20140018420A1 (en) 2014-01-16
US9913821B2 (en) 2018-03-13
CY1115602T1 (el) 2017-01-04
MXPA05008784A (es) 2006-05-25
EP2813511A2 (en) 2014-12-17
US20130345460A1 (en) 2013-12-26
US8846976B2 (en) 2014-09-30
CN100386336C (zh) 2008-05-07
US20210299168A1 (en) 2021-09-30
US20060020026A1 (en) 2006-01-26
EP1601680A4 (en) 2008-05-28

Similar Documents

Publication Publication Date Title
DK1601680T3 (da) Fremgangsmåder til fremstilling af organiske jern(iii)forbindelser
NO2022026I1 (no) Secukinumab - forlenget SPC
DK1575416T3 (da) Fremgangsmåder til diagnosticering af præeklampsi
IS8513A (is) Lífræn efnasambönd
ATE477257T1 (de) Piperidinylamino-thienoä2,3-dü- pyrimidinverbindungen
NO20055688D0 (no) Organiske forbindelser
ATE404546T1 (de) Substituierte n-sulfonylaminobenzyl-2- phenoxyacetamidverbindungen
DK1651034T3 (da) Organiske forbindelser
DK1812448T3 (da) Organiske forbindelser
DE502005000334D1 (de) Spannvorrichtung
DK1866297T3 (da) Fremgangsmåde til fremstilling af en aminomethyl-thiazolforbindelse
DK1574493T3 (da) Fremgangsmåde til fremstilling af anthracendiether
NO20055170D0 (no) Organiske forbindelser
DK1644573T3 (da) Fremgangsmåde til fremstilling af markisestoffer
ATE384719T1 (de) Dioxazinyl-substituierte thienylsulfonylaminocarbonylverbindungen
SE0402103D0 (sv) Novel compounds
EE00444U1 (et) Fosforiühend
SE0400022D0 (sv) New compounds
DK1932835T3 (da) Fremgangsmåde til fremstilling af 2,3-dihydropyridazinforbindelse
SE0400254D0 (sv) New compounds
DE502005000315D1 (de) Spannvorrichtung
UA9723S (uk) Міні-бар
SE0402391D0 (sv) Novelheterocyclic compounds
DOP2004000959A (es) Compuestos
SE0400286D0 (sv) Novel Compounds